Prior studies in patients diagnosed with CLL have shown an increase in defective circulating CD8+ T cells displaying a terminally differentiated phenotype compared to aged-matched healthy donors [18–21, 31, 32]. The gene discussed is CD8A; the disease is B-cell chronic lymphocytic leukemia.